BPIA Submits Comments to DPR
BPIA submitted comments regarding policy for addressing missing/incomplete data during the scientific evaluation process
Read MoreBPIA submitted comments regarding policy for addressing missing/incomplete data during the scientific evaluation process
Read MoreBPIA filed comments regarding EPA’s Draft Guidance Regarding Endangered Species Act Consideration.
Read MoreBPIA submits comments regarding Draft Guidance on Field Trial Requirements for Efficacy and Phytotoxicity.
Read MoreBPIA submits comments regarding proposed changes to the California Pesticide Registration Branch workload assignments.
Read MoreBPIA applauds the bipartisan introduction of the Plant Biostimulant Act of 2023 in the Senate and the U.S. House of Representatives (H.R. 1472). BPIA thanks Senators Mike Braun (R-IN) and Alex Padilla (D-CA) as well as Congressmen Jimmy Panetta (D-CA) and Jim Baird (R-IN) for sponsoring the bill.
Read MoreBPIA and other industry stakeholders suggested the PMRA consider reviewing and modernizing regulations for dual property products containing crop protection and crop health improvement properties to enable registration of these products under single label.
Read MoreView presentations from the BPIA 2023 Annual Meeting here.
Read MoreBPIA hosted a virtual listening session regarding biostimulants to support the National Biotechnology and Biomanufacturing Initiative.
Read MoreBPIA provided input to the White House Office of Science and Technology Policy regarding the Coordinated Framework to accelerate biotechnology innovation and grow America’s bioeconomy.
Read MoreBPIA provided a response to the PMRA’s request for comments regarding PRO2022-01 Pre-Consultation – Proposed Regulatory Amendments to the Pest Control Products Regulations
Read MoreBPIA filed comments regarding ANPR concerning USDA-AMS-NOP’s request for comments on how to rectify the USDA organic regulations’ references to outdated EPA policy on inert ingredients used in pesticide products.
Read MoreBPIA applauds the reauthorization of the Pesticide Registration Improvement Act. PRIA 5 provides necessary resources to EPA’s Office of Pesticide Programs including the Biopesticides and Pollution Prevention Division.
Read MoreBPIA provided comments on the Natural Resources Conservation Service Request for Information on the implementation of the Inflation Reduction Act funding.
Read MoreThe Journal of Regulatory Science publishes the United States Biostimulant Industry Recommended Guidelines to Assess Efficacy, Composition, and Safety of Plant Biostimulant Products.
Read MoreBPIA joins research effort focused on learning more at field-level about biological products.
Read MoreCongressman Jimmy Panetta discussed the Plant Biostimulant Act during a House Ag Committee hearing on soil health practices.
Read MoreBPIA and FACA commend the U.S. Department of Agriculture for its consideration and selection of pilot projects through its Partnerships for Climate-Smart Commodities.
Read MoreIn May, US Congressmen Jimmy Panetta (D-CA) and Jim Baird (R-IN) introduced the bipartisan Plant Biostimulant Act of 2022 (H.R. 7752).
Read MoreBPIA provided comments regarding the USDA’s Animal and Plant Health Inspection Service’s Strategic Plan Framework,
Read MoreMaking Sense of Biologicals, a series from AgNet West that dives into various topics with unbiased experts in the field of biologics, talked with BPIA.
Read More